Categories: Cardiovascular disease

7 9/26/2018

STAT’s cheerleading coverage of prescription fish oil capsule lacks crucial context

3/14/2017

Reuters Health lays out pros and cons of high resolution screening for heart patients; skimps on study limitations

4/28/2016

Medical Daily story on Mediterranean diet study mostly echoes news release

4/25/2016

NBC story built around one patient’s amazing stroke recovery; skimps on data suggesting result is unusual

5 4/14/2016

Solid effort by NBC on saturated fat study, though story lacked hard numbers on findings

1/7/2016

Newer blood pressure meds “as good as old ones” — but at doing what exactly?

1/7/2016

A gloss over costs in coverage of competing blood pressure meds — but also some strengths

10/15/2015

“Wine can help” those with type 2 diabetes, says LA Times, but benefits aren’t quantified (and are actually quite small)

3 10/8/2015

Optimal balance of competing views on value of CT heart scans

9/26/2015

Texting your way to heart health? NPR thoroughly examines the evidence

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Alan Cassels @AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680 Retweet on Twitter 13614314893264076806 Like on Twitter 13614314893264076808 Twitter 1361431489326407680

Retweet on Twitter HealthNewsReview.org Retweeted

RxISK @RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843 Retweet on Twitter 13614204592841318439 Like on Twitter 136142045928413184318 Twitter 1361420459284131843

HealthNewsReview.org @HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532 Retweet on Twitter 13602149497049825325 Like on Twitter 136021494970498253210 Twitter 1360214949704982532